X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.68
Delayed Data
As of Apr 24
 +0.04 / +2.44%
Today’s Change
1.61
Today|||52-Week Range
4.14
-26.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses337.3K466.4K196.1K298.2K
 
 
 
 
 
Research And Development23.7K15.8K9.3K--
 
 
 
 
Total Operating Expenses337.3K466.4K196.1K298.2K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-337.3K-466.4K-196.1K-294.1K
 
 
 
 
 
Other Expenses-688.1K-1.0M1.3M16.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.0M-1.5M1.6M-2.1K
 
 
 
 
 
Net Income-1.0M-1.5M1.6M-2.1K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.3M5.1M5.1M5.1M
 
 
 
 
 
Shares To Calculate EPS Diluted3.3M5.1M5.1M5.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31------
 
 
EPS Diluted-$0.31-$0.32$0.31-$0.00